Research team from University of Göttingen develops drug approach against bacterial infections
Antibiotics are among the most important discoveries of modern medicine and have saved millions of lives since the discovery of penicillin almost 100 years ago. Many diseases caused by bacterial infections – such as pneumonia, meningitis or septicaemia – are successfully treated with antibiotics. However, bacteria can develop resistance to antibiotics which then leaves doctors struggling to find effective treatments. Particularly problematic are pathogens which develop multi-drug resistance and are unaffected by most antibiotics. This leads to severe disease progression in affected patients, often with a fatal outcome. Scientists all over the world are therefore engaged in the search for new antibiotics. Researchers at the University of Göttingen and the Max Planck Institute for Biophysical Chemistry Göttingen have now described a promising new approach involving “antivitamins” to develop new classes of antibiotics. The results were published in the journal Nature Chemical Biology.
Antivitamins are substances that inhibit the biological function of a genuine vitamin. Some antivitamins have a similar chemical structure to those of the actual vitamin whose action they block or restrict. For this study, Professor Kai Tittmann’s team from the Göttingen Center for Molecular Biosciences at the University of Göttingen worked together with Professor Bert de Groot’s group from the Max Planck Institute for Biophysical Chemistry Göttingen and Professor Tadgh Begley from Texas A&M University (USA). Together they investigated the mechanism of action at the atomic level of a naturally occurring antivitamin of vitamin B1. Some bacteria are able to produce a toxic form of this vital vitamin B1 to kill competing bacteria. This particular antivitamin has only a single atom in addition to the natural vitamin in a seemingly unimportant place and the exciting research question was why the action of the vitamin was still prevented or “poisoned”.
Tittmann’s team used high-resolution protein crystallography to investigate how the antivitamin inhibits an important protein from the central metabolism of bacteria. The researchers found that the “dance of the protons”, which can normally be observed in functioning proteins, almost completely ceases to function and the protein no longer works. “Just one extra atom in the antivitamin acts like a grain of sand in a complex gear system by blocking its finely tuned mechanics,” explains Tittmann. It is interesting to note that human proteins are able to cope relatively well with the antivitamin and continue working. The chemist de Groot and his team used computer simulations to find out why this is so. “The human proteins either do not bind to the antivitamin at all or in such a way that they are not ‘poisoned’,” says the Max Planck researcher. The difference between the effects of the antivitamin on bacteria and on human proteins opens up the possibility of using it as an antibiotic in the future and thus creating new therapeutic alternatives.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Antivitamins
- Feed has no items.
Go deeper with Google Headlines on:
Antivitamins
[google_news title=”” keyword=”antivitamins” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
New antibiotics
- Better medical record-keeping needed to fight antibiotic overuse
A lack of detailed record-keeping in clinics and emergency departments may be getting in the way of reducing the inappropriate use of antibiotics, a pair of new studies suggests. In one of the studies ...
- India cracks down on antibiotic misuse
India's drug regulator has directed state counterparts to provide a list of antibiotic combinations licensed for manufacturing and marketing within two weeks to combat misuse. This move follows ...
- Govt lens on misuse of antibiotics, DCGI seeks report within 2 weeks
This comes in the backdrop of excessive and irrational use of antibiotics in India which fail to work in patients when they are routinely exposed to these drugs.
- Major weaknesses and loopholes in new antibiotic law, campaign group finds
New legislation that came into force today banning the routine use of antibiotics on farm animals has been described as lagging behind Europe by campaign groups. The legislation bans the routine use ...
- New antibiotic rules contain ‘loopholes and weaknesses’
New rules have come into force for ending routine preventative antibiotic use in farming, but campaigners want the UK government to go further. From Friday 17 May, prophylactic use of farm antibiotics ...
Go deeper with Google Headlines on:
New antibiotics
[google_news title=”” keyword=”new antibiotics” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]